Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silviu Itescu

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
The Spine Journal : Official Journal of the North American Spine Society|January 21, 2014
Allogeneic mesenchymal progenitor cells for posterolateral lumbar spine fusion in sheepDonna L Wheeler, Joseph M Lane, Howard B Seim, et al.
European Journal of Heart Failure|November 9, 2011
Short- and long-term outcomes of intracoronary and endogenously mobilized bone marrow stem cells in the treatment of ST-segment elevation myocardial infarction: a meta-analysis of randomized control trialsHendrik Zimmet, Pramote Porapakkham, Pornwalee Porapakkham, et al.
Circulation|March 13, 2002
Intravenous pulse administration of cyclophosphamide is an effective and safe treatment for sensitized cardiac allograft recipientsSilviu Itescu, Elizabeth Burke, Katherine Lietz, et al.
Human Immunology|March 2, 2002
B-cell activation and allosensitization after left ventricular assist device implantation is due to T-cell activation and CD40 ligand expressionMichael Schuster, Alfred Kocher, Ranjit John, et al.
Circulation|May 14, 2003
Use of rapamycin slows progression of cardiac transplantation vasculopathyDonna Mancini, Sean Pinney, Daniel Burkhoff, et al.
Circulation|October 19, 2005
Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery diseaseKatherine Lietz, Ranjit John, Elizabeth Burke, et al.
Conference Proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference|October 20, 2007
Engineered cardiac tissues for in vitro assessment of contractile function and repair mechanismsDo Eun Kim, Eun Jung Lee, Timothy P Martens, et al.
Transplantation|March 28, 2003
Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacyKatherine Lietz, Ranjit John, Ainat Beniaminovitz, et al.
Transplant Immunology|February 18, 2004
Anti-HLA antibodies in heart transplantationElena R Vasilescu, Eric K Ho, Ludwika de la Torre, et al.
Transplantation|June 9, 2005
Anti-human leukocyte antigen antibodies are associated with restenosis after percutaneous coronary intervention for cardiac allograft vasculopathyMatthew McKay, Sean Pinney, Simon Gorwara, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
The Spine Journal : Official Journal of the North American Spine Society|January 21, 2014
Allogeneic mesenchymal progenitor cells for posterolateral lumbar spine fusion in sheepDonna L Wheeler, Joseph M Lane, Howard B Seim, et al.
European Journal of Heart Failure|November 9, 2011
Short- and long-term outcomes of intracoronary and endogenously mobilized bone marrow stem cells in the treatment of ST-segment elevation myocardial infarction: a meta-analysis of randomized control trialsHendrik Zimmet, Pramote Porapakkham, Pornwalee Porapakkham, et al.
Circulation|March 13, 2002
Intravenous pulse administration of cyclophosphamide is an effective and safe treatment for sensitized cardiac allograft recipientsSilviu Itescu, Elizabeth Burke, Katherine Lietz, et al.
Human Immunology|March 2, 2002
B-cell activation and allosensitization after left ventricular assist device implantation is due to T-cell activation and CD40 ligand expressionMichael Schuster, Alfred Kocher, Ranjit John, et al.
Circulation|May 14, 2003
Use of rapamycin slows progression of cardiac transplantation vasculopathyDonna Mancini, Sean Pinney, Daniel Burkhoff, et al.
Circulation|October 19, 2005
Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery diseaseKatherine Lietz, Ranjit John, Elizabeth Burke, et al.
Conference Proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference|October 20, 2007
Engineered cardiac tissues for in vitro assessment of contractile function and repair mechanismsDo Eun Kim, Eun Jung Lee, Timothy P Martens, et al.
Transplantation|March 28, 2003
Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacyKatherine Lietz, Ranjit John, Ainat Beniaminovitz, et al.
Transplant Immunology|February 18, 2004
Anti-HLA antibodies in heart transplantationElena R Vasilescu, Eric K Ho, Ludwika de la Torre, et al.
Transplantation|June 9, 2005
Anti-human leukocyte antigen antibodies are associated with restenosis after percutaneous coronary intervention for cardiac allograft vasculopathyMatthew McKay, Sean Pinney, Simon Gorwara, et al.
Pageof 7